Patients' management of migraine and chronic daily headache: A study of the members of the Migraine Action Association (United Kingdom)

Headache

Volumn 45, Issue 5, 2005, Pages 571-581

  Peters, Michele ^a   Abu Saad, Huda Huijer ^a,b   Robbins, Ian ^a,c   Vydelingum, Vasso ^a   Dowson, Andrew ^d   Murphy, Margaret ^a  

^a UNIVERSITY OF SURREY   (United Kingdom)

^b AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^c ST GEORGE S HOSPITAL   (United Kingdom)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Chronic daily headache; Management; Migraine; Patient

Indexed keywords

ACETYLSALICYLIC ACID PLUS BUTALBITAL PLUS CAFFEINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIEMETIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUTALBITAL PLUS CAFFEINE PLUS PARACETAMOL; CAFFEINE; CAFFEINE PLUS PARACETAMOL PLUS PROPYPHENAZONE; CALCIUM CHANNEL BLOCKING AGENT; CODEINE; CODEINE PLUS DICLOFENAC; ERGOTAMINE; HERBACEOUS AGENT; MINERAL; NON PRESCRIPTION DRUG; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PARACETAMOL; SEROTONIN AGONIST; TRIPTAN; UNCLASSIFIED DRUG; VITAMIN;

ACUPUNCTURE; ADULT; AGED; ALTERNATIVE MEDICINE; ARTICLE; CHRONIC DAILY HEADACHE; CONTROLLED STUDY; FEMALE; HEALTH CARE ACCESS; HEALTH PRACTITIONER; HOMEOPATHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MANIPULATIVE MEDICINE; MEDICAL SPECIALIST; MIGRAINE; MIGRAINE WITH AURA; PRIORITY JOURNAL; PROPHYLAXIS; QUESTIONNAIRE; SOCIAL SUPPORT;

FEMALE; GREAT BRITAIN; HEADACHE DISORDERS; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; QUESTIONNAIRES; REFERRAL AND CONSULTATION; SELF CARE; SOCIAL SUPPORT;

EID: 20544440753     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2005.05111.x     Document Type: Article

References (26)

1. Breslau N, Rasmussen BK. The impact of migraine: epidemiology, risk factors and co-morbidities. Neurology. 2001;56(6 suppl 1):S4-S12.
2. Scher AI, Stewart WF, Liberman J, Lipton RB. Prevalence of frequent headache in a population sample. Headache. 1998;38:497-506.
3. Lanteri-Minet M, Auray J-P, El Hasnaoui A, et al. Prevalence and description of chronic daily headache in the general population in France. Pain. 2003;102:143-149.
4. Lu S-R, Fuh J-L, Chen W-T, Juang K-D, Wang S-J. Chronic daily headache in Taipei, Taiwan: prevalence, follow-up and outcome predictors. Cephalalgia. 2001;21:980-986.
5. Meletiche DM, Lofland JH, Young WB. Quality of life differences between patients with episodic and transformed migraine. Headache. 2001;41:573-578.
6. Michel P, Pariente P, Duru G, Dreyfuss J-P, Chabriat H, Henry P. MIG ACCESS: a population-based, nationwide, comparative survey of access to care in migraine in France. Cephalalgia. 1996;16:50-55.
7. Lipton RB, Goadsby PJ, Sawyer JPC, Blakeborough P, Stewart WF. Migraine: diagnosis and assessment of disability. Rev Contemp Pharmacother. 2000;11:63-73.
8. Peters M, Huijer Abu-Saad H, Vydelingum V. Dowson AJ, Murphy M. Patients' decision-making for migraine and chronic daily headache management. A qualitative study. Cephalalgia. 2003;23:833-841.
9. Peters M, Huijer Abu-Saad H, Vydelingum V, Dowson AJ, Murphy M. Migraine and chronic daily headache management: a qualitative study on the patients' perceptions. Scand J Caring Sci. 2004;18:294-303.
10. Stang PE, Osterhaus JT, Celentano DD. Migraine. Patterns of healthcare use. Neurology. 1994;44(suppl 4):S47-S55.
11. Silberstein SD, Goadsby PJ, Lipton RB. Management of migraine: an algorithmic approach. Neurology. 2000;55(suppl 2):S46-S52.
12. Sullivan M. The new subjective medicine: taking the patient's point of view on health care and health. Soc Sci Med. 2003;56:1595-1604.
13. Sakai F, Igarashi H. Prevalence of migraine in Japan: a nationwide study. Cephalalgia. 1997;17:15-22.
14. Wang S-J, Fuh J-L, Young Y-H, Lu S-R, Shia B-C. Frequency and predictors of physician consultations for headache. Cephalalgia. 2001;21:25-30.
15. MacGregor EA, Brandes JL, Eikerman A. Migraine prevalence and treatment patterns: the global migraine and zolmitriptan evaluation study. Headache. 2003;43:19-26.
16. Galego JCB, Cipullo JP, Cordeiro JA, Tognola WA. Clinical features of episodic migraine and transformed migraine. A comparative study. Arq Neuropsiquiatr. 2002;60:912-916.
17. Diener HC, Katasarva Z. Analgesic/abortive overuse and misuse in chronic daily headache. Curr Pain Headache Rep. 2001;5:545-550.
18. Lipton RB, Stewart WF. Acute migraine therapy: do doctors understand what patients with migraine want from therapy? Headache. 1999;39(suppl 2):S20-S26.
19. Adelman JU, Von Seggern RL, Mannix LK. Migraine headaches: implications for management from a nationwide patient survey. Headache Q. 2000;11:105-112.
20. Dowson AJ, Jagger S. The UK migraine patient survey: quality of life and treatment. Curr Med Res Opin. 1999;15:241-253.
21. Lipton RB, Diamonds, Reed M, Diamond ML, Stewart WF. Migraine diagnosis and treatment: results from the American Migraine Study II. Headache. 2001;41:638-645.
22. Lipton RB, Scher AI, Steiner TJ, et al. Patterns of health care utilization for migraine in England and in the United States. Neurology. 2003;60:441-448.
23. Brandes JL. Global trends in migraine care. Results from the MAZE study. CNS Drugs. 2002;16(suppl 1):13-18.
24. Lucas C, Auray J-P, Gaudin A-F, et al. Use and misuse of triptans in France: data from the GRIM2000 population survey. Cephalagia. 2004;24:197-205.
25. Holman H, Lorig K. Patients as partners in managing chronic disease. Partnership is a prerequisite for effective and efficient health care. Br Med J. 2000;320:526-527.
26. Bodenheimer T, Lorig K, Holman H, Grumbach K. Patient self-management of chronic disease in primary care. JAMA. 2002;288:2469-2475.